Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Current Leases (2019 - 2026)

Mesoblast's (MEOBF) quarterly Current Leases came in at $5.1 million in Q2 2026, up 41.45% year-over-year from $3.6 million in Q2 2025, and down 13.99% quarter-over-quarter from $5.9 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Current Leases (2019 - 2026) Analysis & Trends

Mesoblast has disclosed Current Leases across 8 years of filings, most recently posting $5.1 million for Q2 2026.

  • In Q2 2026, Current Leases rose 41.45% year-over-year to $5.1 million; the TTM figure through Jun 2026 stood at $5.1 million (up 41.45% YoY), while the FY2026 annual figure was $5.1 million, up 41.45% from the prior year.
  • Current Leases came in at $5.1 million for Q2 2026 at Mesoblast, down from $5.9 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $8.1 million in Q1 2022 to a low of $2.0 million in Q2 2024.
  • Average Current Leases over 5 years is $5.0 million, with a median of $4.9 million recorded in 2022.
  • Year-over-year, Current Leases slumped 48.17% in 2023 and surged 83.56% in 2025.
  • Over 5 years, Current Leases stood at $5.0 million in 2022, then slumped by 32.28% to $3.4 million in 2023, then soared by 40.28% to $4.8 million in 2024, then advanced by 24.04% to $5.9 million in 2025, then declined by 13.99% to $5.1 million in 2026.
  • Per Business Quant data, the three most recent Current Leases figures were $5.1 million in Q2 2026, $5.9 million in Q4 2025, and $3.6 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.81 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 18.65 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 2.67 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 2.99 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 15.21 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 1.06 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 14.16 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - 5.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.07 Mn
Dec 31, 2025 5.89 Mn
Jun 30, 2025 3.58 Mn
Dec 31, 2024 4.75 Mn
Jun 30, 2024 1.95 Mn
Dec 31, 2023 3.39 Mn
Jun 30, 2023 3.67 Mn
Mar 31, 2023 4.65 Mn
Dec 31, 2022 5.00 Mn
Sep 30, 2022 6.35 Mn
Jun 30, 2022 7.09 Mn
Mar 31, 2022 8.05 Mn
Dec 31, 2021 7.94 Mn
Sep 30, 2021 7.56 Mn
Jun 30, 2021 8.49 Mn
Mar 31, 2021 6.48 Mn
Dec 31, 2020 6.51 Mn
Sep 30, 2020 7.05 Mn
Jun 30, 2020 6.32 Mn
Mar 31, 2020 5.76 Mn